Skip to search.
 STI Up0.30%

Cubist Pharmaceuticals Inc. (CBST)

-NasdaqGS

56.00 Up 0.54(0.97%) 02:07 SGT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2012Dec 31, 2011Dec 31, 2010
Total Revenue 926,359   753,972   636,458  
Cost of Revenue230,057  172,864  140,765  
Gross Profit 696,302   581,108   495,693  
Operating Expenses
Research Development277,729  184,533  157,854  
Selling General and Administrative142,767  254,765  148,240  
Non Recurring38,700  9,279   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 237,106   132,531   189,599  
Income from Continuing Operations
Total Other Income/Expenses Net(4,519)3,673  (9,710)
Earnings Before Interest And Taxes232,587  136,204  179,889  
Interest Expense32,991  31,415  25,580  
Income Before Tax199,596  104,789  154,309  
Income Tax Expense45,521  71,766  59,984  
Minority Interest -   -   -  
Net Income From Continuing Ops154,075  33,023  94,325  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 154,075   33,023   94,325  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 154,075   33,023   94,325  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.